BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19995533)

  • 1. [Indication for bone scans in early breast cancer staging].
    de la Cueva L; Liévano P; Navarro P; Arroyo E; Añaños M; González M; García MC; Fuerte A; Colmenarejo F; Baringo T; Abós MD
    Rev Esp Med Nucl; 2009; 28(6):273-7. PubMed ID: 19995533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of the baseline bone scan in breast cancer.
    Coleman RE; Rubens RD; Fogelman I
    J Nucl Med; 1988 Jun; 29(6):1045-9. PubMed ID: 3373314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system.
    Lee JE; Park SS; Han W; Kim SW; Shin HJ; Choe KJ; Oh SK; Youn YK; Noh DY; Kim SW
    Cancer; 2005 Aug; 104(3):499-503. PubMed ID: 15968691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radionuclide bone scanning in patients with breast carcinoma. Study of lesions by stages, locations and diagnostic assessment].
    Benítez A; Torres M; García A; Rebollo AC; Pacheco C; Vallejo JA; Contreras PI; Infante J; Mateo A
    Rev Esp Med Nucl; 1998; 17(6):435-41. PubMed ID: 9873131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planar Bone Scan Versus Computerized Tomography in Staging Locally Advanced Breast Cancer in Asymptomatic Patients: Does Bone Scan Change Patient Management Over Computerized Tomography?
    Bansal GJ; Vinayan Changaradil D
    J Comput Assist Tomogr; 2018; 42(1):19-24. PubMed ID: 28786907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioisotope bone scans in the preoperative staging of hepatopancreatobiliary cancer.
    Sheth H; Javed SS; Hilson AJ; Buscombe JR; Davidson BR
    Br J Surg; 2005 Feb; 92(2):203-7. PubMed ID: 15521077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the assessment of the central skeleton sufficient for osseous staging in breast cancer patients? A retrospective approach using bone scans.
    Krammer J; Engel D; Schnitzer A; Kaiser CG; Dinter DJ; Brade J; Schoenberg SO; Wasser K
    Skeletal Radiol; 2013 Jun; 42(6):787-91. PubMed ID: 23287962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
    Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
    Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of excretory urography, ultrasonography, computerized tomography, and liver and bone scan in the staging of bilharzial bladder cancer in Saudi Arabia.
    Hanash KA; Bissada NK; Abla A; Esmail D; Dowling A
    Cancer; 1984 Jul; 54(1):172-6. PubMed ID: 6232995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is bone scanning of value in patients with breast cancer?
    Spencer GR; Khan M; Bird C; Seymour R; Brown TR; Collins CD
    Acta Chir Scand; 1981; 147(4):247-8. PubMed ID: 6459704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging.
    McCartan DP; Prichard RS; MacDermott RJ; Rothwell J; Geraghty J; Evoy D; Quinn CM; Skehan SJ; O'Doherty A; McDermott EW
    Br J Surg; 2016 Jun; 103(7):839-44. PubMed ID: 27004443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of a positive baseline bone scan in breast cancer.
    Ho YY; Chan YH
    Australas Radiol; 2005 Feb; 49(1):21-6. PubMed ID: 15727605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
    Yang SN; Liang JA; Lin FJ; Kao CH; Lin CC; Lee CC
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):325-8. PubMed ID: 12073051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma.
    Mettler FA; Christie JH; Garcia JF; Baldwin MH; Wicks JD; Bartow SA
    Radiology; 1981 Dec; 141(3):777-80. PubMed ID: 6272356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone scanning in patients with breast carcinoma. Should it be a routine examination in every stage group?
    Inoue Y; Nishi T; Hirose T; Schichijo Y; Ibukuro K
    Rofo; 1985 Dec; 143(6):676-8. PubMed ID: 3001860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.
    Yeh KA; Fortunato L; Ridge JA; Hoffman JP; Eisenberg BL; Sigurdson ER
    Ann Surg Oncol; 1995 Jul; 2(4):319-24. PubMed ID: 7552621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.
    Buscombe JR; Holloway B; Roche N; Bombardieri E
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of metastasis among rib abnormalities on bone scans in breast cancer patients.
    Li Q; Chen Z; Zhao Y; Li X; Pan H; Xia T; Chen L; Xu Z; Zhou W; Liu X
    Sci Rep; 2015 May; 5():9587. PubMed ID: 25939860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
    Nakamoto Y; Osman M; Wahl RL
    Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.